Company Comparison
DNA Script vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | DNA Script | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Paris, France | San Diego |
| Founded | 2014 | — |
| Status | Active | Active |
| Last Funding Stage | Series B | Series A |
| Total Funding | $134M | $48M |
| Valuation | — | — |
What They Build
DNA Script
Biotechnology company developing enzymatic DNA synthesis technology to enable on-demand, decentralized production of synthetic DNA for research and therapeutics.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
DNA Script
AI Therapeutics
No investors listed.
Sector Overlap
Both DNA Script and AI Therapeutics operate in Biotech.
Browse all Biotech companies →